Several types of targeted medicines are now used for colorectal cancer.
Medicines that target new blood vessel growth
Tumors need new blood vessels to grow beyond a certain size. Some targeted medicines work by blocking new blood vessels from forming. These include:
- Bevacizumab.
- Ramucirumab.
- Ziv-aflibercept.
- Fruquintinib.
Medicines that target the EGRF protein
Epidermal growth factor receptor or EGFR is a protein that's often found in high levels on cancer cells and helps them grow. Some targeted medicines work by attacking the EGFR protein. These include:
These medicines don't work in people whose cancer cells have certain gene mutations. Your doctor will test a sample of your tumor for these mutations before you get one of these medicines.
Medicines with other targets
Regorafenib is a type of targeted medicine known as a multikinase inhibitor. It blocks several different proteins (kinases) in cancer cells that normally help them grow.
Encorafenib is another targeted therapy medicine that can shrink tumors or slow cancer growth. It works by attacking BRAF protein that helps cancer cells grow.
Trastuzumab combined with pertuzumab, tucatinib, or lapatinib target a protein called HER2. It may help when there is too much of this growth-promoting protein on cancer cells.
Larotrectinib, entrectinib, and repotrectinib target a specific NTRK gene change found in some colorectal cancer cells. They might be used if other treatments aren't working anymore.